Abbott to Reopen Baby Formula Plant

May 17, 2022
Abbott Laboratories and the FDA have agreed on a roadmap to open its troubled baby formula plant.

Abbott Laboratories and the FDA have agreed on a roadmap to open its troubled baby formula plant, but the company says it will be more than a month before the move can have any effect on the market.

The closure of the Abbott formula plant in Sturgis, Mich., contributed to a nationwide shortage of infant formula that has reached crisis proportions. The plant was closed down in February after evidence of microbial contamination was discovered there.

On May 16, the FDA and Abbott announced a consent decree to get the plant up and running. The plant could resume operations in two weeks if a court approves, although Abbott issued a statement saying it would be six to eight weeks before new supplies of Similac and other products would reach retail shelves.

The FDA also confirmed on Monday that it is relaxing regulations to allow easier imports of baby formula from overseas. Nestlé announced that it would fly extra shipments of formula into the U.S. from Switzerland and Holland.

Sponsored Recommendations

Troubleshoot: Grittiness in gluten free cookies

Learn how to adjust gluten free cookie recipes for a softer texture.

Clabber Girl: Rising Success

Uncover how Clabber Girl Corporation achieved a remarkable 7% growth and improved manufacturing efficiency by seamlessly integrating Vicinity's batch manufacturing solution with...

Intelligent Blends: Taking Technology to the Next Level

Find out how our friends at Intelligent Blends use VicinityFood and Microsoft Dynamics GP to produce the best coffee around.

Key ingredient: Mother Murphy's Laboratories

Flavorings manufacturer Mother Murphy’s Laboratories integrates front office with production facility — improving operations from initial order to final invoice.